GERM

Amplify Treatments, Testing and Advancements ETF
GERM

Delisted

GERM was delisted on the 5th of September, 2024.

Back to rankings

17 hedge funds and large institutions have $6.27M invested in Amplify Treatments, Testing and Advancements ETF in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.55M
2
+$165K
3
+$33

Top Sellers

1
-$798K
2
-$454K
3
-$173K
4
UBS Group
UBS Group
Switzerland
-$67.2K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$23.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.55M
2
$672K
3
$378K
4
$330K
5
$182K
6
$68.5K
7
$31.3K
8
$26.6K
9
$7.16K
10
$6K
11
$5.92K
12
$4.13K
13
$3.58K
14
$2.86K
15
$2.04K
16
$839
17
$33
18
–
19
–